← Back to headlines
BioNTech Faces Post-Pandemic Crisis Amid Falling Demand and Restructuring
BioNTech, known for its COVID-19 vaccines, is grappling with declining demand, internal restructuring, and the departure of its founders, as it pivots to ambitious cancer trials to secure its future.
6 May, 14:53 — 6 May, 14:53
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Oriental Mindoro Jeepney Drivers Receive Government Cash Aid
just now
Jelgava Municipality Takes Control of Waste Management Company Amid KNAB Investigation
4m ago
Latvia Implements Reaction Test for Shared Vehicles, Bolt Reports Failed Tests
13m ago